Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Pluvicto
Manufacturing
Novartis brings isotope production in house amid global shortage
Novartis is establishing in-house production of isotopes for its radiotherapies in the U.S. amid a global shortage of the nuclear component.
Angus Liu
Sep 4, 2024 11:24am
Novartis CEO sees IRA impact ‘manageable’ in short run
Jul 18, 2024 11:05am
Novartis gears up for key expansions of 3 cancer drugs
Apr 23, 2024 3:37pm
Novartis gears up for Pluvicto filing as survival data clear up
Apr 5, 2024 3:00am
Exelixis joins Novartis on FDA waiting list in prostate cancer
Jan 25, 2024 8:00am
Novartis' largest Pluvicto plant approved by FDA
Jan 5, 2024 11:36am
